메인으로

Number	Category	Presentation Title
13	Targeted therapeutics	In Vivo Evaluation of 68Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenografted Model
12	Targeted therapeutics	Efficacy of newly discovered DNA aptamers targeting AXL in a lung cancer cell with acquired resistance to Erlotinib
11	Targeted therapeutics	Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer
10	Targeted therapeutics	Specific Inhibition of Soluble γc Receptor Attenuates Collagen-Induced Arthritis by Modulating the Inflammatory T Cell Responses
9	Targeted therapeutics	Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast
8	Targeted therapeutics	Mechanistic understanding of insulin receptor modulation: Implications for the development of anti-diabetic drugs
7	Targeted therapeutics	Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles
6	Targeted therapeutics	Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal Fibrosis
5	Targeted therapeutics	Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation
4	Targeted therapeutics	Aptamer-conjugated gold nanorod for photothermal ablation of epidermal growth factor receptor-overexpressed epithelial cancer
3	Targeted therapeutics	Development of an aptamer-conjugated fluorescent nanoprobe for MMP2
2	Targeted therapeutics	Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles
1	Targeted therapeutics	Periostin-binding DNA Aptamer Inhibits Breast Cancer Growth and Metastasis